Back to news

Smithson Inv.Trust - Result of AGM

Back to news
RNS Number : 7758X
Smithson Investment Trust PLC
27 April 2023

Smithson Investment Trust plc

Legal Entity Identifier: 52990070BDK2OKX5TH79

Results of AGM - 27 April 2023

Smithson Investment Trust plc (the "Company") is pleased to announce that all the resolutions put forward at its Annual General Meeting held earlier today were passed. 

The text of all the resolutions is contained in the Notice of Annual General Meeting published on the Company's website (www.smithson.co.uk).

The proxy votes received were as follows:

 

Resolution

In Favour / Discretionary

Against

Withheld

 



Votes

%

Votes

%

Votes

1.

To receive and adopt the Annual Report and Accounts.

59,849,638

99.99

2,511

0.01

9,401

2.

To approve the Directors Remuneration Policy.

59,722,212

99.84

98,318

0.16

41,020

3.

To approve the Directors Remuneration Report.

59,723,242

99.84

96,787

0.16

41,521

4.

To re-elect Diana Dyer Bartlett as a Director of the Company.

43,269,010

75.84

13,787,242

24.16

2,805,298

5.

To re-elect Lord St John of Bletso as a Director of the Company.

56,117,959

93.81

3,703,234

6.19

40,357

6.

To re-elect Jeremy Attard-Manche as a Director of the Company.

58,813,257

98.32

1,004,549

1.68

43,744

7.

To elect Denise Hadgill as a Director of the Company.

59,767,245

99.90

61,184

0.10

 

33,121

8.

To re-appoint Deloitte LLP as auditor to the Company.

59,792,065

99.91

55,328

0.09

14,157

9.

To authorise the Directors to fix the remuneration of the auditor until the conclusion of the next Annual General Meeting of the Company.

59,827,784

99.97

17,009

0.03

16,757

10.

To authorise the Directors to allot securities in the Company up to an amount representing 10% of the issued share capital.

59,794,422

99.95

28,519

0.05

38,609

11.

To authorise the Directors to allot securities in the Company up to an additional amount representing 10% of the issued share capital.

59,788,964

99.91

54,967

0.09

17,619

12.

To disapply the pre-emption rights in relation to the allotment of shares up to an amount representing 10% of the issued share capital. *

58,680,690

98.09

1,140,096

1.91

40,764

13.

To disapply the pre-emption rights in relation to the allotment of shares up to an additional amount representing 10% of the issued share capital. *

58,676,796

98.05

1,164,312

1.95

20,442

14.

To authorise the Company to make market purchases of ordinary shares in the Company. *

59,233,994

98.97

619,469

1.03

8,087

15.

That the Directors be authorised to call general meetings (other than annual general meetings) on not less than 14 clear days' notice. *

59,669,876

99.73

161,776

0.27

29,898

*Special resolution

Resolution 4, the re-election of the Chairman of the Board received less than 80% of the votes cast in favour. The Board understands that the vote against the resolution is predominantly in respect of a large shareholder's view on the diversity of the Board.  The Board proposes to consult with shareholders to discuss any concerns that have influenced their voting. A statement detailing the outcome of the Company's consultation with its shareholders, including the views received from shareholders and any actions taken as a result, will be published by the Company by no later than 27 October 2023 in accordance with the AIC Code of Corporate Governance.

On the record date for voting at the meeting, the Company's issued ordinary share capital consisted of 177,107,958 ordinary shares. There were 9,210,000 treasury shares in issue. Therefore, the total number of ordinary shares with voting rights in the Company was 167,897,958.

Copies of all the resolutions passed, other than ordinary business, will be submitted to the National Storage Mechanism and will shortly be available for inspection at:https://data.fca.org.uk/#/nsm/nationalstoragemechanism

27 April 2023

Enquiries

Apex Listed Companies Services (UK) Limited

Company Secretary

  +44 2039 748046

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
RAGUBVNRONUSUAR